Aoxing Pharmaceutical (AXN) Reports Q1 EPS of $0.02

Aoxing Pharmaceutical (NYSE: AXN) reported Q1 EPS of $0.02, versus $0.00 reported last year. Revenue for the quarter came in at $8.75 million, versus $4.57 million reported last year.

For earnings history and earnings-related data on Aoxing Pharmaceutical (AXN) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Freeport Q3 2026 copper output meets targets; gold sales deferred
• Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'